5-[7-[5-amino-3-carbamoyl-2-(trifluoromethyl)phenyl]-2-(1,2,3,5,6,7-hexahydropyrrolizin-8-ylmethoxy)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-4-yl]-N,N,3-trimethyl-4,6,7,8-tetrahydropyrazolo[1,5-a][1,4]diazepine-2-carboxamide;1,1-difluoroethene
C36H44F5N9O4 — CID 178025570
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[7-[5-amino-3-carbamoyl-2-(trifluoromethyl)phenyl]-2-(1,2,3,5,6,7-hexahydropyrrolizin-8-ylmethoxy)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-4-yl]-N,N,3-trimethyl-4,6,7,8-tetrahydropyrazolo[1,5-a][1,4]diazepine-2-carboxamide;1,1-difluoroethene
5-[7-[5-amino-3-carbamoyl-2-(trifluoromethyl)phenyl]-2-(1,2,3,5,6,7-hexahydropyrrolizin-8-ylmethoxy)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-4-yl]-N,N,3-trimethyl-4,6,7,8-tetrahydropyrazolo[1,5-a][1,4]diazepine-2-carboxamide;1,1-difluoroethene (PubChem CID 178025570) has the molecular formula C36H44F5N9O4 and a molecular weight of 761.80 g/mol. Its IUPAC name is 5-[7-[5-amino-3-carbamoyl-2-(trifluoromethyl)phenyl]-2-(1,2,3,5,6,7-hexahydropyrrolizin-8-ylmethoxy)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-4-yl]-N,N,3-trimethyl-4,6,7,8-tetrahydropyrazolo[1,5-a][1,4]diazepine-2-carboxamide;1,1-difluoroethene.
Molecular Properties
| Compound Name | 5-[7-[5-amino-3-carbamoyl-2-(trifluoromethyl)phenyl]-2-(1,2,3,5,6,7-hexahydropyrrolizin-8-ylmethoxy)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-4-yl]-N,N,3-trimethyl-4,6,7,8-tetrahydropyrazolo[1,5-a][1,4]diazepine-2-carboxamide;1,1-difluoroethene |
|---|---|
| PubChem CID | 178025570 |
| Molecular Formula | C36H44F5N9O4 |
| Molecular Weight | 761.80 g/mol |
| Exact Mass | 761.34 |
| IUPAC Name | 5-[7-[5-amino-3-carbamoyl-2-(trifluoromethyl)phenyl]-2-(1,2,3,5,6,7-hexahydropyrrolizin-8-ylmethoxy)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-4-yl]-N,N,3-trimethyl-4,6,7,8-tetrahydropyrazolo[1,5-a][1,4]diazepine-2-carboxamide;1,1-difluoroethene |
| SMILES | C=C(F)F.Cc1c(C(=O)N(C)C)nn2c1CN(c1nc(OCC34CCCN3CCC4)nc3c1COC(c1cc(N)cc(C(N)=O)c1C(F)(F)F)C3)CCC2 |
| InChI | InChI=1S/C34H42F3N9O4.C2H2F2/c1-19-25-16-44(9-6-12-46(25)42-28(19)31(48)43(2)3)30-23-17-49-26(21-13-20(38)14-22(29(39)47)27(21)34(35,36)37)15-24(23)40-32(41-30)50-18-33-7-4-10-45(33)11-5-8-33;1-2(3)4/h13-14,26H,4-12,15-18,38H2,1-3H3,(H2,39,47);1H2 |
| InChIKey | DRBZBSQRIGIBLS-UHFFFAOYSA-N |
| XLogP | 5.01 |
| TPSA | 157.96 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 11 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 54 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 761.80 |
| LogP ≤ 5 | 5.01 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 11 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'aniline', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 178025570 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.